Drug information for NYDRAZID
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
100MG/ML
Discontinued
ISONIAZID
Isoniazid
SANDOZ
8662
TABLET; ORAL
100MG
Discontinued
ISONIAZID
Isoniazid
BRISTOL MYERS SQUIBB
8392
Drug Adverse Effects information for NYDRAZID
Role code
Indications
Reaction
# Reports
C
COLITIS ULCERATIVE
BLOOD POTASSIUM DECREASED
4
C
COLITIS ULCERATIVE
BLOOD POTASSIUM INCREASED
4
C
COLITIS ULCERATIVE
BLOOD SODIUM DECREASED
4
C
COLITIS ULCERATIVE
BLOOD SODIUM INCREASED
4
C
COLITIS ULCERATIVE
BRONCHITIS
4
C
COLITIS ULCERATIVE
BRONCHOPNEUMONIA
4
C
COLITIS ULCERATIVE
CANDIDA TEST POSITIVE
4
C
COLITIS ULCERATIVE
CARDIOMEGALY
4
C
COLITIS ULCERATIVE
CELL DEATH
4
C
COLITIS ULCERATIVE
DISSEMINATED TUBERCULOSIS
4
C
COLITIS ULCERATIVE
HAEMATOCRIT DECREASED
4
C
COLITIS ULCERATIVE
HAEMOGLOBIN DECREASED
4
C
COLITIS ULCERATIVE
HEPATIC NECROSIS
4
C
COLITIS ULCERATIVE
HEPATIC STEATOSIS
4
C
COLITIS ULCERATIVE
KLEBSIELLA TEST POSITIVE
4
C
COLITIS ULCERATIVE
MULTI-ORGAN FAILURE
4
C
COLITIS ULCERATIVE
PANCREATIC DISORDER
4
C
COLITIS ULCERATIVE
PLATELET COUNT DECREASED
4
C
COLITIS ULCERATIVE
PNEUMOCONIOSIS
4
C
COLITIS ULCERATIVE
PULMONARY EMBOLISM
4
C
COLITIS ULCERATIVE
RED BLOOD CELL COUNT DECREASED
4
C
COLITIS ULCERATIVE
RENAL FAILURE ACUTE
4
C
COLITIS ULCERATIVE
RESPIRATORY FAILURE
4
C
COLITIS ULCERATIVE
SEPSIS
4
C
COLITIS ULCERATIVE
SPLENIC INFARCTION
4
C
COLITIS ULCERATIVE
SPLENIC NECROSIS
4
C
COLITIS ULCERATIVE
WHITE BLOOD CELL COUNT DECREASED
4
Ads by Google